You've been managing your cholesterol the best you can, but during your last check-up, you received the same message: Your ...

A significant breakthrough in heart disease prevention arrived on July 16, 2026, with the FDA approval of Lipfendra ...

FDA has approved Lipfendra, developed by American pharmaceutical company Merck, for adults with high LDL cholesterol. It ...

While tried-and-true high cholesterol treatments like statins are an important way to protect your heart if you have elevated ...

Lipfendra, the first once-daily oral PCSK9 inhibitor, was shown to reduce LDL cholesterol by roughly 56% to 60% when combined ...

Lipfendra, to be taken once a day, is designed to help lower cholesterol levels beyond what statins alone can achieve.

The drug is the first oral form of a class of powerful cholesterol-fighting drugs called PCSK9 inhibitors.

The FDA has approved Lipfendra, the first oral PCSK9 inhibitor, for the treatment of high cholesterol. Two medical experts explain why this matters.

The US FDA approved Merck’s cholesterol-lowering pill, it said on Thursday, the first in a class of drugs dominated by ...

The U.S. Food and Drug Administration has approved Merck's Lipfendra (enlicitide), making it the first oral PCSK9 inhibitor ...

The FDA approved enlicitide (Lipfendra; Merck), the first oral PCSK9 inhibitor for lowering low-density lipoprotein ...

The U.S. FDA has approved Merck's new cholesterol-lowering pill, Lipfendra. This oral medication works by blocking the PCSK9 ...